nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.115	0.137	CbGbCtD
Mesoridazine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.108	0.129	CbGbCtD
Mesoridazine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.108	0.129	CbGbCtD
Mesoridazine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.098	0.116	CbGbCtD
Mesoridazine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.098	0.116	CbGbCtD
Mesoridazine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0846	0.1	CbGbCtD
Mesoridazine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0821	0.0974	CbGbCtD
Mesoridazine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0743	0.0881	CbGbCtD
Mesoridazine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0743	0.0881	CbGbCtD
Mesoridazine—DRD2—nerve—acquired immunodeficiency syndrome	0.00498	0.0609	CbGeAlD
Mesoridazine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00417	0.051	CbGeAlD
Mesoridazine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00328	0.0402	CbGeAlD
Mesoridazine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.0028	0.0342	CbGeAlD
Mesoridazine—DRD3—nervous system—acquired immunodeficiency syndrome	0.00265	0.0324	CbGeAlD
Mesoridazine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.00255	0.0312	CbGeAlD
Mesoridazine—HTR6—nervous system—acquired immunodeficiency syndrome	0.00255	0.0312	CbGeAlD
Mesoridazine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00248	0.0304	CbGeAlD
Mesoridazine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.00245	0.03	CbGeAlD
Mesoridazine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00226	0.0277	CbGeAlD
Mesoridazine—DRD2—retina—acquired immunodeficiency syndrome	0.00206	0.0252	CbGeAlD
Mesoridazine—DRD3—brain—acquired immunodeficiency syndrome	0.00202	0.0247	CbGeAlD
Mesoridazine—HTR6—brain—acquired immunodeficiency syndrome	0.00195	0.0238	CbGeAlD
Mesoridazine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00175	0.0214	CbGeAlD
Mesoridazine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.00153	0.0187	CbGeAlD
Mesoridazine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00147	0.018	CbGeAlD
Mesoridazine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.00147	0.018	CbGeAlD
Mesoridazine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.00147	0.018	CbGeAlD
Mesoridazine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00142	0.0173	CbGeAlD
Mesoridazine—HTR2A—retina—acquired immunodeficiency syndrome	0.00136	0.0166	CbGeAlD
Mesoridazine—KCNH2—blood—acquired immunodeficiency syndrome	0.00136	0.0166	CbGeAlD
Mesoridazine—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.00131	0.0161	CbGeAlD
Mesoridazine—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.00131	0.016	CbGeAlD
Mesoridazine—KCNH2—vagina—acquired immunodeficiency syndrome	0.00126	0.0154	CbGeAlD
Mesoridazine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00124	0.0152	CbGeAlD
Mesoridazine—DRD2—lung—acquired immunodeficiency syndrome	0.00121	0.0148	CbGeAlD
Mesoridazine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.00119	0.0146	CbGeAlD
Mesoridazine—CHRM2—brain—acquired immunodeficiency syndrome	0.00117	0.0143	CbGeAlD
Mesoridazine—HRH1—digestive system—acquired immunodeficiency syndrome	0.00114	0.014	CbGeAlD
Mesoridazine—HTR2C—brain—acquired immunodeficiency syndrome	0.00113	0.0138	CbGeAlD
Mesoridazine—DRD2—nervous system—acquired immunodeficiency syndrome	0.00112	0.0137	CbGeAlD
Mesoridazine—KCNH2—nervous system—acquired immunodeficiency syndrome	0.0011	0.0135	CbGeAlD
Mesoridazine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00108	0.0132	CbGeAlD
Mesoridazine—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.00106	0.013	CbGeAlD
Mesoridazine—HRH1—vagina—acquired immunodeficiency syndrome	0.00101	0.0123	CbGeAlD
Mesoridazine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000955	0.0117	CbGeAlD
Mesoridazine—HRH1—lung—acquired immunodeficiency syndrome	0.000955	0.0117	CbGeAlD
Mesoridazine—HTR1A—brain—acquired immunodeficiency syndrome	0.000947	0.0116	CbGeAlD
Mesoridazine—HTR2A—blood—acquired immunodeficiency syndrome	0.00091	0.0111	CbGeAlD
Mesoridazine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000884	0.0108	CbGeAlD
Mesoridazine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000876	0.0107	CbGeAlD
Mesoridazine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.00087	0.0106	CbGeAlD
Mesoridazine—DRD2—brain—acquired immunodeficiency syndrome	0.000856	0.0105	CbGeAlD
Mesoridazine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000851	0.0104	CbGeAlD
Mesoridazine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000843	0.0103	CbGeAlD
Mesoridazine—KCNH2—brain—acquired immunodeficiency syndrome	0.000843	0.0103	CbGeAlD
Mesoridazine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000829	0.0101	CbGeAlD
Mesoridazine—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000815	0.00996	CbGeAlD
Mesoridazine—HTR2A—lung—acquired immunodeficiency syndrome	0.000798	0.00975	CbGeAlD
Mesoridazine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000739	0.00903	CbGeAlD
Mesoridazine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000711	0.0087	CbGeAlD
Mesoridazine—HRH1—brain—acquired immunodeficiency syndrome	0.000676	0.00827	CbGeAlD
Mesoridazine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000673	0.00823	CbGeAlD
Mesoridazine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000653	0.00799	CbGeAlD
Mesoridazine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000648	0.00792	CbGeAlD
Mesoridazine—HTR2A—brain—acquired immunodeficiency syndrome	0.000564	0.0069	CbGeAlD
Mesoridazine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000514	0.00629	CbGeAlD
Mesoridazine—Acepromazine—ALB—acquired immunodeficiency syndrome	0.000204	0.226	CrCbGaD
Mesoridazine—Thioproperazine—ALB—acquired immunodeficiency syndrome	0.0002	0.221	CrCbGaD
Mesoridazine—Pipotiazine—ALB—acquired immunodeficiency syndrome	0.000197	0.218	CrCbGaD
Mesoridazine—Thiothixene—ALB—acquired immunodeficiency syndrome	0.000197	0.218	CrCbGaD
Mesoridazine—HTR6—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000114	0.00154	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000114	0.00154	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000114	0.00154	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000114	0.00154	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000114	0.00153	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000114	0.00153	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000113	0.00152	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000112	0.00151	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00011	0.00148	CbGpPWpGaD
Mesoridazine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	0.000107	0.118	CrCbGaD
Mesoridazine—HTR6—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000105	0.00142	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000104	0.0014	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000104	0.0014	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000104	0.00139	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000103	0.00139	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000102	0.00138	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000102	0.00137	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.98e-05	0.00134	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.9e-05	0.00133	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.9e-05	0.00133	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	9.88e-05	0.00133	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.82e-05	0.00132	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.8e-05	0.00132	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	9.69e-05	0.00131	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	9.69e-05	0.00131	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.65e-05	0.0013	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	9.36e-05	0.00126	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	9.02e-05	0.00122	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.99e-05	0.00121	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	8.98e-05	0.00121	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	8.98e-05	0.00121	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.95e-05	0.00121	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	8.94e-05	0.0012	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.85e-05	0.00119	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.83e-05	0.00119	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	8.8e-05	0.00119	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	8.8e-05	0.00119	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.69e-05	0.00117	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.68e-05	0.00117	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.63e-05	0.00116	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.63e-05	0.00116	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.58e-05	0.00116	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.58e-05	0.00116	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.55e-05	0.00115	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	8.54e-05	0.00115	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	8.45e-05	0.00114	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	8.45e-05	0.00114	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	8.4e-05	0.00113	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	8.4e-05	0.00113	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	8.38e-05	0.00113	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	8.16e-05	0.0011	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	8.12e-05	0.00109	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	7.98e-05	0.00107	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.92e-05	0.00107	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.89e-05	0.00106	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.88e-05	0.00106	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.82e-05	0.00105	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.8e-05	0.00105	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.79e-05	0.00105	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.78e-05	0.00105	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	7.77e-05	0.00105	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.77e-05	0.00105	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.76e-05	0.00105	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.76e-05	0.00105	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.74e-05	0.00104	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	7.67e-05	0.00103	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	7.67e-05	0.00103	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.65e-05	0.00103	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	7.63e-05	0.00103	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	7.63e-05	0.00103	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.62e-05	0.00103	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.57e-05	0.00102	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.57e-05	0.00102	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	7.47e-05	0.00101	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.45e-05	0.001	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.45e-05	0.001	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.44e-05	0.001	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.44e-05	0.001	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.42e-05	0.000999	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.42e-05	0.000999	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.37e-05	0.000993	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.32e-05	0.000986	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.32e-05	0.000986	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.3e-05	0.000983	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.3e-05	0.000983	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.28e-05	0.000981	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.28e-05	0.000981	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	7.26e-05	0.000978	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.2e-05	0.00097	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.17e-05	0.000965	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.17e-05	0.000965	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	7.16e-05	0.000965	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.1e-05	0.000957	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	7.05e-05	0.000949	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	7.03e-05	0.000947	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.92e-05	0.000932	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	6.89e-05	0.000928	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.85e-05	0.000923	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	6.76e-05	0.000911	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.74e-05	0.000908	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.73e-05	0.000907	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.73e-05	0.000907	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.73e-05	0.000906	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.7e-05	0.000902	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.64e-05	0.000895	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.63e-05	0.000893	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.63e-05	0.000893	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.62e-05	0.000891	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.61e-05	0.000891	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.61e-05	0.000891	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	6.61e-05	0.00089	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.6e-05	0.000888	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.51e-05	0.000877	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.51e-05	0.000877	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.51e-05	0.000877	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	6.43e-05	0.000866	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	6.39e-05	0.000861	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.33e-05	0.000853	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.3e-05	0.000848	CbGpPWpGaD
Mesoridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	6.14e-05	0.000827	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.12e-05	0.000825	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.12e-05	0.000825	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.11e-05	0.000824	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.03e-05	0.000813	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.84e-05	0.000786	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.81e-05	0.000782	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.79e-05	0.00078	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.76e-05	0.000776	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.75e-05	0.000774	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.72e-05	0.00077	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	5.72e-05	0.00077	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.64e-05	0.00076	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.56e-05	0.000749	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.55e-05	0.000748	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.54e-05	0.000746	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.53e-05	0.000745	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.47e-05	0.000737	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.46e-05	0.000735	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.45e-05	0.000734	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.37e-05	0.000723	CbGpPWpGaD
Mesoridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	5.33e-05	0.000718	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.33e-05	0.000718	CbGpPWpGaD
Mesoridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	5.32e-05	0.000717	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.3e-05	0.000714	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.26e-05	0.000708	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.23e-05	0.000705	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.2e-05	0.0007	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.2e-05	0.0007	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.12e-05	0.00069	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.08e-05	0.000685	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.05e-05	0.00068	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.04e-05	0.000679	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.03e-05	0.000678	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5e-05	0.000674	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.99e-05	0.000672	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.97e-05	0.000669	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.96e-05	0.000668	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.95e-05	0.000667	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.91e-05	0.000662	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.88e-05	0.000657	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.82e-05	0.000649	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.79e-05	0.000646	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.68e-05	0.00063	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.66e-05	0.000627	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.62e-05	0.000622	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.6e-05	0.00062	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.59e-05	0.000619	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.59e-05	0.000618	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.54e-05	0.000612	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.53e-05	0.000611	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.53e-05	0.00061	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.53e-05	0.00061	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.52e-05	0.000609	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.52e-05	0.000609	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.51e-05	0.000607	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.51e-05	0.000607	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.46e-05	0.000601	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.23e-05	0.00057	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.2e-05	0.000565	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.16e-05	0.000561	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.15e-05	0.00056	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.1e-05	0.000553	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.09e-05	0.000551	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.98e-05	0.000536	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.98e-05	0.000536	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.96e-05	0.000533	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.91e-05	0.000527	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.91e-05	0.000527	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.91e-05	0.000526	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.91e-05	0.000526	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.9e-05	0.000525	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.84e-05	0.000518	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.84e-05	0.000518	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.84e-05	0.000517	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.56e-05	0.00048	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.49e-05	0.00047	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.45e-05	0.000464	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.43e-05	0.000462	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.4e-05	0.000457	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.38e-05	0.000455	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.35e-05	0.000451	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.33e-05	0.000448	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.11e-05	0.000418	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.09e-05	0.000416	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.04e-05	0.000409	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.03e-05	0.000408	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.02e-05	0.000407	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.98e-05	0.000402	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.98e-05	0.000401	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.97e-05	0.0004	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.94e-05	0.000396	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.93e-05	0.000395	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.93e-05	0.000394	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.92e-05	0.000394	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.89e-05	0.000389	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.88e-05	0.000388	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.88e-05	0.000388	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.84e-05	0.000382	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.73e-05	0.000367	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.68e-05	0.000361	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.68e-05	0.000361	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.67e-05	0.000359	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.63e-05	0.000355	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.62e-05	0.000354	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.62e-05	0.000353	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.58e-05	0.000347	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.42e-05	0.000327	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.41e-05	0.000325	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.06e-05	0.000277	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.05e-05	0.000276	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.79e-05	0.000242	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.79e-05	0.000241	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.79e-05	0.00024	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.78e-05	0.000239	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000212	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.57e-05	0.000211	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.55e-05	0.000209	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.55e-05	0.000208	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000208	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000207	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.52e-05	0.000205	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.51e-05	0.000204	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000192	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	1.36e-05	0.000183	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.21e-05	0.000163	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.05e-05	0.000142	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.05e-05	0.000141	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.26e-06	0.000125	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.11e-06	0.000123	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.09e-06	0.000122	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.95e-06	0.000121	CbGpPWpGaD
